(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis. by Long Li (6555)

Scenario groups and number of scenarios based on the different starting points. by Fabian Mitze (21084251)

Subjects:

Guidelines and policy changes for different alert levels in Gauteng. The time intervals are separated by points of inflection identified in Edholm <i>et al</i>. [10]; these points separate time periods where the rate of cumulative cases was increasing from periods when the rate of cumulative cases was decreasing [10], Fig 1].... by Folashade B. Agusto (3663010)

“…[<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0325619#pone.0325619.ref010" target="_blank">10</a>]; these points separate time periods where the rate of cumulative cases was increasing from periods when the rate of cumulative cases was decreasing [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0325619#pone.0325619.ref010" target="_blank">10</a>], Fig 1]. …”

Effect sizes (if > 0.5) for the comparison of increasing load vs. decreasing for the iliocostalis muscle. by Christoph Anders (4068499)

Subjects:

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

Effect sizes (if > 0.5) for the comparison of increasing load vs. decreasing load for the multifidus muscle. by Christoph Anders (4068499)

Subjects:

Effect sizes (if > 0.5) for the comparison of increasing load vs. decreasing load for the longissimus muscle. by Christoph Anders (4068499)

Subjects:

Effect sizes (if > 0.5) for the comparison of increasing load vs. decreasing load for the rectus abdominis muscle. by Christoph Anders (4068499)

Subjects:

Effect sizes (if > 0.5) for the comparison of increasing load vs. decreasing load for the internal oblique muscle. by Christoph Anders (4068499)

Subjects:

Effect sizes (if > 0.5) for the comparison of increasing load vs. decreasing load for the external oblique muscle. by Christoph Anders (4068499)

Subjects:

Changes in AL (A) and SE (B) according to the treatment time estimation curve in patients given 0.125% atropine. by Zi-Rong Chen (9227618)

Subjects:

Table 2 - Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study by Zi-Rong Chen (9227618)

Subjects:

An <i>In Situ</i> TEM Study of the Diffusivity of Gold Atoms in Nanocomposite Thin Films by Zirconia Co-Deposition: Implication for Neuromorphic Devices by Alberto Casu (1285227)

Subjects:

An <i>In Situ</i> TEM Study of the Diffusivity of Gold Atoms in Nanocomposite Thin Films by Zirconia Co-Deposition: Implication for Neuromorphic Devices by Alberto Casu (1285227)

Subjects:

An <i>In Situ</i> TEM Study of the Diffusivity of Gold Atoms in Nanocomposite Thin Films by Zirconia Co-Deposition: Implication for Neuromorphic Devices by Alberto Casu (1285227)

Subjects:

An <i>In Situ</i> TEM Study of the Diffusivity of Gold Atoms in Nanocomposite Thin Films by Zirconia Co-Deposition: Implication for Neuromorphic Devices by Alberto Casu (1285227)

Subjects:

An <i>In Situ</i> TEM Study of the Diffusivity of Gold Atoms in Nanocomposite Thin Films by Zirconia Co-Deposition: Implication for Neuromorphic Devices by Alberto Casu (1285227)

Subjects:

An <i>In Situ</i> TEM Study of the Diffusivity of Gold Atoms in Nanocomposite Thin Films by Zirconia Co-Deposition: Implication for Neuromorphic Devices by Alberto Casu (1285227)

Subjects:

An <i>In Situ</i> TEM Study of the Diffusivity of Gold Atoms in Nanocomposite Thin Films by Zirconia Co-Deposition: Implication for Neuromorphic Devices by Alberto Casu (1285227)

Subjects:

Group-level narrow- and broad-band spectral changes after hemispherotomy reveal a marked EEG slowing of the isolated cortex, robust across patients. by Michele Angelo Colombo (22446342)

“…This decrease was larger in the disconnected than in the contralateral cortex. …”